NEXGEL, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by NEXGEL, INC. (NXGL) on August 21, 2026. The report discloses significant changes in executive leadership and board composition effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- CEO Departure: Adam R. Levy was terminated as Chief Executive Officer without Cause and resigned from the Board of Directors and all other officer positions effective August 21, 2026.
- Interim CEO Appointment: Brian Kieser was appointed as Interim Chief Executive Officer effective August 21, 2026. Mr. Kieser has served on the Board since May 6, 2026.
- Background of Interim CEO: Mr. Kieser is the Founder and CEO of Fountainhead Lifesciences and CEO of Sequence LifeScience, Inc. The Company maintains a strategic partnership with Sequence.
Outlook, Risks, and Unusual Items
- Separation Agreement: The Company and Mr. Levy are negotiating a Separation Agreement and Release. Material terms are not yet finalized, and an amendment to this 8-K will be filed once the agreement is executed.
- Compensation: The material terms of Mr. Kieser's compensation as Interim CEO have not yet been determined. An amendment will be filed once these terms are set.
- Emerging Growth Company: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Monitor for the upcoming amendment to this 8-K detailing the final terms of Adam R. Levy's separation agreement.
- Verify the finalized compensation package for Interim CEO Brian Kieser in future filings.
- Review the strategic partnership between NEXGEL and Sequence LifeScience, Inc., given Mr. Kieser's dual role as CEO of Sequence.
- Check for any subsequent filings regarding the appointment of a permanent CEO to replace the interim arrangement.